Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group (Q48527134)
Jump to navigation
Jump to search
scientific article published in November 1995
Language | Label | Description | Also known as |
---|---|---|---|
English | Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group |
scientific article published in November 1995 |
Statements
Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group (English)
Liberman UA
Weiss SR
Bröll J
Minne HW
Quan H
Bell NH
Rodriguez-Portales J
Downs RW Jr
Dequeker J
Favus M
1 November 1995
333
22
1437-1443